(HRMY) Harmony Biosciences - Performance 12.3% in 12m
HRMY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-13.92%
#75 in Peer-Group
Rel. Strength
61.16%
#2955 in Stock-Universe
Total Return 12m
12.26%
#53 in Peer-Group
Total Return 5y
-10.92%
#78 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 13.5 |
| P/E Forward | 9.56 |
| High / Low | USD |
|---|---|
| 52 Week High | 41.49 USD |
| 52 Week Low | 27.94 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 19.89 |
| Buy/Sell Signal +-5 | 0.10 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: HRMY (12.3%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: HRMY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for HRMY
| Total Return (including Dividends) | HRMY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -3.68% | 4.35% | 1.11% |
| 3 Months | -3.93% | -6.89% | 5.58% |
| 12 Months | 12.26% | -5.08% | 10.51% |
| 5 Years | -10.92% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | HRMY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -4.7% | 65.8% | 69.9% |
| 3 Months | 43.6% | -72% | 69.3% |
| 12 Months | -4.2% | -62.2% | 43.2% |
| 5 Years | -25.5% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #147 | -7.69% | -4.74% |
| 3 Month | #105 | 3.18% | -9.01% |
| 12 Month | #53 | 18.27% | 1.58% |
| 5 Years | #75 | -34.96% | -53.01% |
FAQs
Does Harmony Biosciences (HRMY) outperform the market?
Yes,
over the last 12 months HRMY made 12.26%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months HRMY made -3.93%, while XLV made -6.89%.
Performance Comparison HRMY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
HRMY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -6.5% | -4.8% | 0.7% | 2% |
| US NASDAQ 100 | QQQ | -6.2% | -5.2% | 1.5% | 3% |
| German DAX 40 | DAX | -4.3% | -2.9% | -15.6% | -17% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -6.2% | -2.8% | -1.1% | 1% |
| Hongkong Hang Seng | HSI | -7% | -8.7% | -18.3% | -15% |
| India NIFTY 50 | INDA | -4.8% | -2.4% | 1.7% | 14% |
| Brasil Bovespa | EWZ | -8.8% | -4.1% | -19.5% | 3% |
HRMY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -6.1% | -5.2% | -2.1% | -10% |
| Consumer Discretionary | XLY | -5.9% | -1.9% | 10.6% | -5% |
| Consumer Staples | XLP | -6.2% | -3.5% | -0.8% | 5% |
| Energy | XLE | -12.3% | -6.6% | -2.9% | 9% |
| Financial | XLF | -4.9% | -1.1% | -2.1% | -11% |
| Health Care | XLV | -8.4% | -8% | 1.2% | 17% |
| Industrial | XLI | -5.4% | -4% | -4.8% | -6% |
| Materials | XLB | -5.8% | -5.1% | -0.1% | 13% |
| Real Estate | XLRE | -7% | -4.6% | -0.3% | -1% |
| Technology | XLK | -6.8% | -5.7% | 0.3% | 8% |
| Utilities | XLU | -7.9% | -4.2% | -7.6% | -9% |
| Aerospace & Defense | XAR | -5.5% | -9.5% | -16.2% | -30% |
| Biotech | XBI | -6.1% | -11.4% | 11.5% | 20% |
| Homebuilder | XHB | -4.9% | 1.3% | 16.1% | 22% |
| Retail | XRT | -2.6% | -3.5% | 8.7% | 12% |
HRMY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -18.3% | -22.4% | -9.12% | 9% |
| Natural Gas | UNG | -5.7% | -1.1% | -17.6% | 27% |
| Gold | GLD | -10.1% | -9.9% | -29.4% | -35% |
| Silver | SLV | -5.7% | -15% | -18.9% | -10% |
| Copper | CPER | -4% | -5.4% | -14.2% | 4% |
HRMY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -8% | -4.4% | 2.2% | 16% |
| iShares High Yield Corp. Bond | HYG | -7% | -4.2% | -3% | 3% |